Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 811

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult

Open access
Bernie, Towler, Les, Irwig, Paul, Glasziou, Jan, Kewenter, David, Weller, Chris, Silagy · 1998 · BMJ

Abstract

Objective : To review effectiveness of screening for colorectal cancer with faecal occult blood test, Hemoccult, and to consider benefits and harms of screening. Design : Systematic review of trials of Hemoccult screening, with meta-analysis of results from the randomised controlled trials. Subjects : Four randomised controlled trials and two non-randomised trials of about 330 000 and 113 000 people respectively aged ≥ years in five countries. Main outcome measures : Meta-analysis of effects of screening on mortality from colorectal cancer. Results : Quality of trial design was generally high, and screening resulted in a favourable shift in the stage distribution of colorectal cancers in the screening groups. Meta-analysis of mortality results from the four randomised controlled trials showed that those allocated to screening had a reduction in mortality from colorectal cancer of 16% (relative risk 0.84 (95% confidence interval 0.77 to 0.93)). When adjusted for attendance for screening, this reduction was 23% (relative risk 0.77 (0.57 to 0.89)) for people actually screened. If a biennial Hemoccult screening programme were offered to 10 000 people and about two thirds attended for at least one Hemoccult test, 8.5 (3.6 to 13.5) deaths from colorectal cancer would be prevented over a period of 10 years. Conclusion : Although benefits of screening are likely to outweigh harms for populations at high risk of colorectal cancer, more information is needed about the harmful effects of screening, the community's responses to screening, and costs of screening for different healthcare systems before widespread screening can be recommended.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.317.7158.559

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 7

  1. Mulrow CD Oxman AD , eds. Critical appraisal ofs tudies. Cochrane Collaboration handbook [updated 9 December 1996]. Section 6. In: The Cochrane Library [database on disc and CD ROM]. Cochrane Collaboration; Issue 1.Oxford:Update Software; 1997. Updated quarterly.
  2. Petitti DB .Meta-analysis, decision analysis andc ost-effectiveness analysis: methods for quantitative synthesis inm edicine. Oxford:Oxford University Press,1994.
  3. 10.1016/0021-9681(80)90034-X · doi:10.1016/0021-9681(80)90034-x
  4. 10.1002/1097-0142(19880801)62:3<645::AID-CNCR2820620333>3.0.CO;2-# · doi:10.1002/1097-0142(19880801)62:3<645::aid-cncr2820620333>3.0.co;2-#
  5. Church TR Mandel JS Bond JH Ederer F Snover DC Bradley GM .Colon cancer control study: status and current issues. In: Miller AB Chamberlain J Day NE Hakama M Prorok PD , eds. Cancers creening. Cambridge:Cambridge University Press,1991:83–105.
  6. 10.1002/1097-0142(19850701)56:1<95::AID-CNCR2820560116>3.0.CO;2-K · doi:10.1002/1097-0142(19850701)56:1<95::aid-cncr2820560116>3.0.co;2-k
  7. Dunlop, 1992, Screening for large bowel cancer ini ndividuals with a family history of colorectal cancer., Br J Surg, 79, 488, 10.1002/bjs.1800790606 · doi:10.1002/bjs.1800790606

Cited by

See all 811

Metadata

Authors
Bernie, T., Les, I., Paul, G., Jan, K., David, W., & Chris, S.
Venue
BMJ
Publisher
BMJ
Published
1998-08-29
Volume
317
Issue
7158
Pages
559-565
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2009460002
Cited by
811
References
19
FWCI
1.41
Type
journal article
Language
en
Open access
bronze
Licence
www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.